Repertoire Immune Medicines’ $189 Million Series B Financing

Goodwin Procter LLP advised Repertoire Immune Medicines on the deal.Repertoire Immune Medicines announced the completion of its $189 million Series B financing. Joining Flagship Pioneering, Repertoire’s institutional…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now